Stonehearth Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
Stonehearth Capital Management's GILD Position: Q2 2026 in Review
Stonehearth Capital Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,775 shares worth $224K. The stake represents 0.08% of the portfolio and ranks #83 among its holdings. This is a return to the name: Stonehearth Capital Management previously reported a position in GILD as recently as Q4 2023.
Stonehearth Capital Management first reported a position in GILD in Q3 2023 and has held it in 3 quarters since. The position peaked at $261K in Q4 2023. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Stonehearth Capital Management held 1,775 shares of Gilead Sciences worth $224K as of Q2 2026.
- Gilead Sciences was a new Stonehearth Capital Management position in Q2 2026.
- Gilead Sciences made up 0.08% of Stonehearth Capital Management's portfolio in Q2 2026, its #83 holding.
- Stonehearth Capital Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 3 quarters since.
- Stonehearth Capital Management's Gilead Sciences position peaked at $261K in Q4 2023.
- 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Stonehearth Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.